138 related articles for article (PubMed ID: 28489574)
1. Targeting neurokinin-3 receptor: a novel anti-angiogenesis strategy for cancer treatment.
Wang T; Chen S; Wang S; Shi L; Wang C; Zhang J; Gao Y; Li G; Qi Y; An X; Chen L
Oncotarget; 2017 Jun; 8(25):40713-40723. PubMed ID: 28489574
[TBL] [Abstract][Full Text] [Related]
2. FP3: a novel VEGF blocker with anti-angiogenic and anti-tumor effects.
Gao W; Jin K; Lan H; Han N; Cao F; Teng L
Hepatogastroenterology; 2012; 59(120):2543-7. PubMed ID: 22534543
[TBL] [Abstract][Full Text] [Related]
3. Impact of ER520, a candidate of selective estrogen receptor modulators, on in vitro cell growth, migration, invasion, angiogenesis and in vivo tumor xenograft of human breast cancer cells.
Wang L; Wang Y; Du H; Jiang Y; Tang Z; Liu H; Xiang H; Xiao H
Cancer Chemother Pharmacol; 2015 Dec; 76(6):1247-57. PubMed ID: 26464351
[TBL] [Abstract][Full Text] [Related]
4. MART-10, the new brand of 1α,25(OH)2D3 analog, is a potent anti-angiogenic agent in vivo and in vitro.
Chiang KC; Sun CC; Chen MH; Huang CY; Hsu JT; Yeh TS; Chen LW; Kuo SF; Juang HH; Takano M; Kittaka A; Chen TC; Yeh CN; Pang JH
J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):26-34. PubMed ID: 26385607
[TBL] [Abstract][Full Text] [Related]
5. Hemokinins modulate endothelium function and promote angiogenesis through neurokinin-1 receptor.
Song H; Yin W; Zeng Q; Jia H; Lin L; Liu X; Mu L; Wang R
Int J Biochem Cell Biol; 2012 Sep; 44(9):1410-21. PubMed ID: 22554585
[TBL] [Abstract][Full Text] [Related]
6. Development of novel neurokinin 3 receptor (NK3R) selective agonists with resistance to proteolytic degradation.
Misu R; Oishi S; Yamada A; Yamamura T; Matsuda F; Yamamoto K; Noguchi T; Ohno H; Okamura H; Ohkura S; Fujii N
J Med Chem; 2014 Oct; 57(20):8646-51. PubMed ID: 25247671
[TBL] [Abstract][Full Text] [Related]
7. Ursolic acid-loaded chitosan nanoparticles induce potent anti-angiogenesis in tumor.
Jin H; Pi J; Yang F; Wu C; Cheng X; Bai H; Huang D; Jiang J; Cai J; Chen ZW
Appl Microbiol Biotechnol; 2016 Aug; 100(15):6643-6652. PubMed ID: 26883344
[TBL] [Abstract][Full Text] [Related]
8. Platycodin D inhibits tumor growth by antiangiogenic activity via blocking VEGFR2-mediated signaling pathway.
Luan X; Gao YG; Guan YY; Xu JR; Lu Q; Zhao M; Liu YR; Liu HJ; Fang C; Chen HZ
Toxicol Appl Pharmacol; 2014 Nov; 281(1):118-24. PubMed ID: 25250884
[TBL] [Abstract][Full Text] [Related]
9. Anti-angiogenic quassinoid-rich fraction from Eurycoma longifolia modulates endothelial cell function.
Al-Salahi OS; Kit-Lam C; Majid AM; Al-Suede FS; Mohammed Saghir SA; Abdullah WZ; Ahamed MB; Yusoff NM
Microvasc Res; 2013 Nov; 90():30-9. PubMed ID: 23899415
[TBL] [Abstract][Full Text] [Related]
10. Jiedu Xiaozheng Yin, a Chinese herbal formula, inhibits tumor angiogenesis via downregulation of VEGF-A and VEGFR-2 expression in vivo and in vitro.
Cao Z; Lin W; Huang Z; Chen X; Zhao J; Zheng L; Ye H; Liu Z; Liao L; Du J
Oncol Rep; 2013 Mar; 29(3):1080-6. PubMed ID: 23254951
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship study of tachykinin peptides for the development of novel neurokinin-3 receptor selective agonists.
Misu R; Noguchi T; Ohno H; Oishi S; Fujii N
Bioorg Med Chem; 2013 Apr; 21(8):2413-2417. PubMed ID: 23473945
[TBL] [Abstract][Full Text] [Related]
12. Davallia bilabiata exhibits anti-angiogenic effect with modified MMP-2/TIMP-2 secretion and inhibited VEGF ligand/receptors expression in vascular endothelial cells.
Liu CT; Bi KW; Huang CC; Wu HT; Ho HY; S Pang JH; Huang ST
J Ethnopharmacol; 2017 Jan; 196():213-224. PubMed ID: 27993633
[TBL] [Abstract][Full Text] [Related]
13. Suppression of alpha-tocopherol ether-linked acetic acid in VEGF-induced angiogenesis and the possible mechanisms in human umbilical vein endothelial cells.
Chuang CH; Liu CH; Lu TJ; Hu ML
Toxicol Appl Pharmacol; 2014 Dec; 281(3):310-6. PubMed ID: 25447407
[TBL] [Abstract][Full Text] [Related]
14. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
[TBL] [Abstract][Full Text] [Related]
15. Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling.
Chen H; Cong Q; Du Z; Liao W; Zhang L; Yao Y; Ding K
Cancer Lett; 2016 Nov; 382(1):44-52. PubMed ID: 27569654
[TBL] [Abstract][Full Text] [Related]
16. The antiangiogenic effects of polyisoprenylated cysteinyl amide inhibitors in HUVEC, chick embryo and zebrafish is dependent on the polyisoprenyl moiety.
Nkembo AT; Ntantie E; Salako OO; Amissah F; Poku RA; Latinwo LM; Lamango NS
Oncotarget; 2016 Oct; 7(42):68194-68205. PubMed ID: 27626690
[TBL] [Abstract][Full Text] [Related]
17. An antiangiogenic neurokinin-B/thromboxane A2 regulatory axis.
Pal S; Wu J; Murray JK; Gellman SH; Wozniak MA; Keely PJ; Boyer ME; Gomez TM; Hasso SM; Fallon JF; Bresnick EH
J Cell Biol; 2006 Sep; 174(7):1047-58. PubMed ID: 17000881
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of 2,4-disubstituted quinazoline derivatives with potent anti-angiogenesis activities.
Yu G; Li Z; Tang L; Xiong Q
Molecules; 2014 Jun; 19(7):8916-32. PubMed ID: 24972275
[TBL] [Abstract][Full Text] [Related]
19. Vascular disrupting activity of combretastatin analogues.
Porcù E; Salvador A; Primac I; Mitola S; Ronca R; Ravelli C; Bortolozzi R; Vedaldi D; Romagnoli R; Basso G; Viola G
Vascul Pharmacol; 2016 Aug; 83():78-89. PubMed ID: 27235861
[TBL] [Abstract][Full Text] [Related]
20. OSU-A9 inhibits angiogenesis in human umbilical vein endothelial cells via disrupting Akt-NF-κB and MAPK signaling pathways.
Omar HA; Arafa el-SA; Salama SA; Arab HH; Wu CH; Weng JR
Toxicol Appl Pharmacol; 2013 Nov; 272(3):616-24. PubMed ID: 23921148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]